CapsoVision, Inc. Common Stock
$6.33
$0.34 (+5.68%)
$6.01Day Range$6.42
Key Statistics
Market Cap
$316.80M
Shares Outstanding
50.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 2, 2025
Round Lot
100
Locale
US
Trading Data
Day Open
$6.04
Day High
$6.42
Day Low
$6.01
Volume
174.7K
VWAP
$6.27
Prev Close
$5.99
Transactions
--
Acc. Volume
--
About CapsoVision, Inc. Common Stock
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUSSIC 384599 employees18805 COX AVENUE SUITE 250, SARATOGA, CA, 95070(408) 370-4790IPO Jul 2, 2025US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001378325
- Composite FIGI
- BBG00KHZ9QJ2
- Share Class FIGI
- BBG00KHZ9QK0
- Ticker Root
- CV
- SIC Code
- 3845
About CapsoVision, Inc. Common Stock (CV) Stock
CapsoVision, Inc. Common Stock (CV) closed the 2026-09-17 session at $6.33, up 5.68% versus the previous close (+0.34). The stock opened at $6.04 and traded between $6.01 and $6.42 during that session. Session trading volume was 175K shares. The volume-weighted average price (VWAP) is $6.27.
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
CapsoVision, Inc. Common Stock has a market capitalization of $316.8 million. The company operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry classification. CV is listed on the XNAS exchange. The company employs approximately 99 people. CapsoVision, Inc. Common Stock is headquartered in SARATOGA, CA. The recorded listing date is 2025-07-02.
On this page you can find market CV stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector.